Dimed S.A. Distribuidora de Medicamentos (PNVL3) - Total Liabilities
Based on the latest financial reports, Dimed S.A. Distribuidora de Medicamentos (PNVL3) has total liabilities worth R$2.36 Billion BRL (≈ $463.71 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore PNVL3 net assets growth trend to track the company's year-over-year net asset growth rate.
Dimed S.A. Distribuidora de Medicamentos - Total Liabilities Trend (2000–2025)
This chart illustrates how Dimed S.A. Distribuidora de Medicamentos's total liabilities have evolved over time, based on quarterly financial data. See PNVL3 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Dimed S.A. Distribuidora de Medicamentos Competitors by Total Liabilities
The table below lists competitors of Dimed S.A. Distribuidora de Medicamentos ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Satrec Initiative Co. Ltd
KQ:099320
|
Korea | ₩136.20 Billion |
|
Globe Trade Centre S.A.
WAR:GTC
|
Poland | zł2.01 Billion |
|
Palm Landscape Architecture Co Ltd
SHE:002431
|
China | CN¥17.12 Billion |
|
Dahu Aquaculture Co Ltd
SHG:600257
|
China | CN¥844.89 Million |
|
Gigastorage Corp
TW:2406
|
Taiwan | NT$7.15 Billion |
|
Founders Metals Inc.
V:FDR
|
Canada | CA$8.87 Million |
|
European Lithium Ltd
AU:EUR
|
Australia | AU$115.16 Million |
|
Rejlers AB (publ)
ST:REJL-B
|
Sweden | Skr2.12 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Dimed S.A. Distribuidora de Medicamentos's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PNVL3 company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.65 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dimed S.A. Distribuidora de Medicamentos's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dimed S.A. Distribuidora de Medicamentos (2000–2025)
The table below shows the annual total liabilities of Dimed S.A. Distribuidora de Medicamentos from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | R$2.55 Billion ≈ $500.09 Million |
+18.94% |
| 2024-12-31 | R$2.14 Billion ≈ $420.44 Million |
+12.54% |
| 2023-12-31 | R$1.90 Billion ≈ $373.61 Million |
+17.18% |
| 2022-12-31 | R$1.62 Billion ≈ $318.85 Million |
+21.73% |
| 2021-12-31 | R$1.33 Billion ≈ $261.92 Million |
+12.77% |
| 2020-12-31 | R$1.18 Billion ≈ $232.27 Million |
+26.45% |
| 2019-12-31 | R$936.11 Million ≈ $183.68 Million |
+74.50% |
| 2018-12-31 | R$536.46 Million ≈ $105.26 Million |
+2.49% |
| 2017-12-31 | R$523.42 Million ≈ $102.71 Million |
+19.14% |
| 2016-12-31 | R$439.32 Million ≈ $86.20 Million |
+5.65% |
| 2015-12-31 | R$415.82 Million ≈ $81.59 Million |
+1.93% |
| 2014-12-31 | R$407.97 Million ≈ $80.05 Million |
+26.31% |
| 2013-12-31 | R$323.00 Million ≈ $63.38 Million |
+20.89% |
| 2012-12-31 | R$267.18 Million ≈ $52.42 Million |
+9.99% |
| 2011-12-31 | R$242.91 Million ≈ $47.66 Million |
+19.03% |
| 2010-12-31 | R$204.07 Million ≈ $40.04 Million |
+12.61% |
| 2009-12-31 | R$181.22 Million ≈ $35.56 Million |
+25.03% |
| 2008-12-31 | R$144.94 Million ≈ $28.44 Million |
+13.17% |
| 2007-12-31 | R$128.07 Million ≈ $25.13 Million |
+9.89% |
| 2006-12-31 | R$116.55 Million ≈ $22.87 Million |
+6.61% |
| 2005-12-31 | R$109.32 Million ≈ $21.45 Million |
+37.04% |
| 2004-12-31 | R$79.77 Million ≈ $15.65 Million |
+1.76% |
| 2003-12-31 | R$78.40 Million ≈ $15.38 Million |
+38.09% |
| 2002-12-31 | R$56.77 Million ≈ $11.14 Million |
-19.92% |
| 2001-12-31 | R$70.89 Million ≈ $13.91 Million |
+7.66% |
| 2000-12-31 | R$65.85 Million ≈ $12.92 Million |
-- |
About Dimed S.A. Distribuidora de Medicamentos
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.